SEP 11, 2026 · JOURNAL ARTICLE
Association of Cachexia-Related Status With Treatment Outcomes in Advanced Gastric Cancer Receiving First-Line Therapy With or Without Nivolumab
Journal of Gastrointestinal Cancer
Retrospective cohort study identifying mGPS 2 as a time-dependent predictor of overall survival in advanced gastric cancer, but with modest sample size, observational design, and no practice-changing effect size or mechanistic clarity.
Reported
Overall survival, time-dependent…HR 2.17 (95% CI 1.15–4.10)
Overall survival p-value0.017
Progression-free survival, time-d…HR 1.49 (95% CI 0.69–3.20)